Status:
UNKNOWN
A Prospective Cohort Study on the Comorbid Depression in Patients With Newly-diagnosed Epilepsy
Lead Sponsor:
Shanghai Zhongshan Hospital
Collaborating Sponsors:
Huashan Hospital
Ruijin Hospital
Conditions:
Epilepsy
Eligibility:
All Genders
18-70 years
Brief Summary
Epilepsy is a chronic brain disease with recurrent seizures and the comorbidity of psychiatric diseases are very common. The prevalence of depression in patients with refractory epilepsy is about 60%....
Detailed Description
Epilepsy is a chronic brain disease with recurrent seizures and the comorbidity of psychiatric diseases are very common. The prevalence of depression in patients with refractory epilepsy is about 60%....
Eligibility Criteria
Inclusion
- meeting the definition of epilepsy according to the new definition issued by ILAE in 2014
- not using antidepressants
- acquiring informed consents
Exclusion
- patients with severe psychiatric symptoms;
- progressive brain diseases
- malignant tumors
- severe cognitive declines
Key Trial Info
Start Date :
November 24 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04517058
Start Date
November 24 2021
End Date
December 31 2023
Last Update
December 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neurology, Zhongshan Hospital, Fudan University, Shanghai, China
Shanghai, Shanghai Municipality, China, 200032